Aptamers Market Research Report-Global Forecast till 2027

Aptamers Market by Type (Nucleic Acid and Peptide Aptamers), Application (Diagnostics, Therapeutics Development), Technology (Selex, X-aptamer and MARAS technique), End Users (Biotechnology and Pharmaceutical Companies)-Global Forecast till 2027

Q: Which factors may limit the aptamers market growth?

Inadequate regulatory structure may limit market growth. . Read More

ID: MRFR/LS/5167-HCR | February 2021 | Region: Global | 85 pages

Please note that the assessment period of report has been updated from 2018–2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario

The Global Aptamers Market is expected to register a growth of significant CAGR 20.2% during the forecast period (2018–2023).

Aptamers are peptide molecules which binds to the targeted lipid, protein, or nucleic acid molecules with high specificity. These are generated rapidly and applied in the inhibition, specific detection, and characterization of proteins. Aptamers can be used as detection reagents, pharmaceutical leads, and functional proteomic levels with antibodies, small molecules, and other aptamers. Aptamers can be modified to have higher affinity and specificity to a large number of targets.

Improvements in aptamer development technologies, increasing Research and development expenditure, and an increasing number of companies investing in this market are some of the key driving factors responsible for the growth of this market. Abundant advantages offered by these small molecules, in comparison to established antibodies, have also led to higher demand for these molecules across a wide range of medical applications. They are chemically synthesized, which eliminates batch-to-batch variation and demands less time for development. Along with this, continuous advancement in technologies is expected to stimulate growth. However, aptamers have failed to meet the necessary safety and efficacy standards in clinical studies. Thus, companies had to terminate their clinical investigation during late-stage clinical studies. This factor is likely to hamper the growth of this market. In addition, other factors, such as little awareness about these technologies in middle and low-income countries and inadequate regulatory structure, may hinder the overall growth.

Segmentation

The Global Aptamers Market has been segmented on the basis of type, application, technology and end users.

On the basis of type, the market has been classified as nucleic acid aptamers and peptide aptamers. The nucleic acid aptamers have been segmented into DNA-Based Aptamers, RNA-Based Aptamers.

On the basis of application, the market has been classified as diagnostics, therapeutics development, research and development, other applications

On the basis of technology, the market has been classified as Selex, X-aptamer and MARAS technique.

On the basis of end users, the market has been classified as academic and government research institutes, biotechnology and pharmaceutical companies, contract research organizations and other end users

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European aptamers market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The aptamers market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The aptamers market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Aptamers Market Share, by Region, 2017 (%)

Global Aptamers Market Share, by Region, 2017 (%)

Source: MRFR Analysis

In the aptamers market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies and high investment and funding to support the development of aptamers. The other factor such as the growing demand for aptamer therapeutics coupled with a rise in a number of research laboratories helps to boost the market.

The European market is expected to hold the second largest market share. Factors such as a rise in research expenses, advancement of technology, the decline in human health, and the necessity for innovative and effective therapies boost the growth of the market in this region. The increasing number of small-scale start-ups, government organizations, rising number of products under clinical investigation, and growing number of academic research laboratories investigating the potential of aptamers are anticipated to support future growth of this market.

Whereas the market share in the Asia-Pacific region is also anticipated to experience growth in the near future due to access to optimal treatment facilities and growing demand for increasing government initiatives, advanced technology, better adoption rate, and rising healthcare expenditure.

The market in the Middle East & Africa is expected to account for the smallest share of the global aptamers market due to an underdeveloped healthcare sector, the dearth of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global aptamers market are Aptamer Sciences, Inc., Aptagen, LLC, Base Pair Biotechnologies, Inc., Ophthotech Corporation, Am Biotechnologies, LLC, Aptamer Solutions Ltd., Aptus Biotech S.L., Neoventures Biotechnology Inc., Somalogic, Inc., Trilink Biotechnologies, Inc., Vivonics, Inc., Noxxon Pharma, and others.

Global Aptamers Market, by Type

Nucleic acid aptamers

DNA-Based Aptamers

RNA-Based Aptamers

Peptide aptamers

Global Aptamers Market, by Application

Diagnostics

Therapeutics development

Research and development

Other applications

Global Aptamers Market, by Technology

Selex

X-aptamer

MARAS technique

Global Aptamers Market, by End Users

Academic and government research institutes

Biotechnology and pharmaceutical companies

Contract research organizations

Other end users

Global Aptamers Market, by Region

Americas
- North America
  - US
  - Canada
- South America

Europe
- Western Europe
  - Germany
  - France
  - Italy
  - Spain
  - UK
  - Rest of Western Europe
- Eastern Europe

Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific

Middle East & Africa
- Middle East
- Africa

Intended Audience

Manufacturers and distributors

Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)

Research institutes

Contract manufacturing organizations (CMOs)

Government associations

Market research and consulting firms

Venture capitalists and investors

Frequently Asked Questions (FAQ) :

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Aptamers Market, by Type

6.1 Introduction

6.2 Nucleic acid aptamers

6.2.1 DNA-Based Aptamers

Market Estimates & Forecast, by Region, 2020-2027